2001
DOI: 10.1155/s1064744901000357
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of Human Immunodeficiency Virus, Hepatitis B andHepatitis C Virus Antibodies and Hepatitis B Antigen AmongCommercial Sex Workers in Japan

Abstract: Objective: To investigate the prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV), and of hepatitis B surface (HBs) antigen in commercial sex workers (CSW) who attended a sexually transmitted disease (STD) clinic in Tokyo. Methods: Surveys were conducted on 308 CSW and 384 control subjects for HIV antibody or 241 control subjects for HBs antibody and antigen and HCV antibody. Results: HIV antibodywas not detected in either CSW or control subjects.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
11
2

Year Published

2006
2006
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(15 citation statements)
references
References 11 publications
2
11
2
Order By: Relevance
“…The 6.2% prevalence of HBsAg carriers among female CSWs in our study is higher than that reported in previous studies of female CSWs in Japan, 14 Uruguay, 18 and South Korea, 11 and in male CSWs in Australia. 17 It is also higher than that in the general female population of South Korea, 1,3,20 in which prevalence ranges from 1.4% to 5%.…”
Section: Discussioncontrasting
confidence: 86%
See 1 more Smart Citation
“…The 6.2% prevalence of HBsAg carriers among female CSWs in our study is higher than that reported in previous studies of female CSWs in Japan, 14 Uruguay, 18 and South Korea, 11 and in male CSWs in Australia. 17 It is also higher than that in the general female population of South Korea, 1,3,20 in which prevalence ranges from 1.4% to 5%.…”
Section: Discussioncontrasting
confidence: 86%
“…Terraut estimated the average seroprevalence of antibodies to HCV among female sex workers to be at 6% in the United States; 6 Laurent and others reported a seroprevalence of 6.6% in the Congo, 13 and Ishi and others reported a seroprevalence of 3.2% in Japan. 14 The HCV seroprevalence of 1.4% in female CSWs in our study is lower than that in most previous reports except another for a report from Japan, 15 and is lower than that in the general female population in South Korea. 16 In addition, CSWs in other countries show a higher seroprevalence than in our study, 8,13,17 despite some differences in the study designs.…”
Section: Discussioncontrasting
confidence: 79%
“…The mean age of participants for all studies ranged from 23.0 to 39.3 years of age. Most studies featured only female participants [ 27 , 29 , 42 , 45 , 46 , 47 , 48 , 50 , 51 , 52 , 53 , 57 , 58 , 59 , 60 , 61 , 64 , 67 , 68 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 92 , 93 , 94 , 95 , 96 , 97 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 107 , ...…”
Section: Resultsmentioning
confidence: 99%
“…The estimated HCV prevalence was 1–1.9%. Published estimates come from a large number of blood donor (138, 143–149) and subgroup‐based studies throughout the country from 1991 to 2010 (140, 141, 145, 147, 150–184). A study of pregnant women in 1990–1994 found a prevalence of 0.3% in women <40, and 1.8% in women over 40, suggestive of the importance of historical risk factors (140).…”
Section: Resultsmentioning
confidence: 99%